Fellow of Ryan Academy of Entrepreneurs

Bachelor of Engineering (B.Eng.)

Labskin have been pioneering the development of a laboratory grown human skin platform for more than 13 years and is the only commercially available lab-grown full thickness human skin model that naturally mimic the skins’ microbiome. With top 20 global consumer health and skincare clients, thousands of industry tests, the good and bad bacteria that naturally exists on human skin is present on Labskin when testing skin care, cosmetics, health care, drug delivery or wound care products. The Labskin test platform and protocols help clients maintain an optimum real-world environment, when testing their new ingredients and existing products, that shows the positive or negative impact on skin’s natural microflora.

Director

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins. Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin microbiome for most of the top 20 global cosmetic company clients and remotely detect and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.

Chief Executive Officer

Founder of a team of scientific, production out-sourced, financial, and marketing experts that transformed laboratory bench medical device solutions for bleeding to the consumer market. An IPO on the London Stock Exchange in 2001. The specialty platform technology centered around FMCG in woundcare, oralcare, CVH and operating in the Nanotech area exploiting more than 45 patents.

Creation of co-branded technology with consumer FMCG resulted in

Sales went from zero to €33m in 5 years with distribution in 42 countries
Co-branding and distribution with 50 partners across 4 continents
Production and distribution acquisitions in China, India, and the UK 
Five Employees in 1996
Company went from a laboratory to manufacturing operations in the Czech Republic (wound-care), China and India (Oralcare) with 210 in manufacturing, sales, and distribution by 2006. 
Company was sold to Hemcon Plc in 2008 for  $55m.

In 2004 Gerard was appointed Managing Partner for Farmabrand Private Equity involved in the privatization of a number of Polish State owned pharmaceutical companies including the negotiation relating to the privatization of the largest generic production facilities under Polish State Treasury ownership with a value of $240 million USD. 

Media coverage of the project http://www.ceepharma.com/news/164873/farmabrand-wants-to-buy-51-or-100-of-phf-ivax-also-interested

Managing Partner

Modern Water was established in 2006 to develop and commercialise water recovery technologies to counter water crisis problems arising from climate change and a growing global population. 

Laboratories and offices in Delaware, US, Shanghai, China and Osaka, Japan, York, UK and Cork and Dublin, Ireland. 

Having invested £20m over the last 14 years on a robust patent portfolio of cutting edge technology, focused on monitoring of contaminated water and decontamination of wastewater, making recycling of water more efficient. Six countries across the world have legislated that Modern Water monitoring test systems are written into their environmental protection legislation.

Managing Director

Skin Trust Club incorporates an artificial intelligence Skincare App and Home Test Kit that provide simple, at-home skin microbiome testing for personalised skincare and skin health tracking. The self-administered skin swab is a remote trial and allows the participant to conduct each stage of the trial without interaction. Skin Trust Club's DNA Test generates a report that consumers can use to manage their custom skincare regime. Analysis of skin attributes provides information to create hundreds of different product combinations to suit a person's unique skin microbiome.

For over 45 years Parity has worked with some of the largest UK organisations to support their growth and make a positive change with their data. Our clients trust us to identify and write their data strategies, provide insight through analytics, assess the maturity of their data processes, devise an end-to-end data lifecycle for their business and support a data-driven environment.

Non Executive Director

Scientific Research
Rinodrive (acquired by DeepVerge in May 2019) drives deeper discovery. Seamlessly and securely take data from any lab source, in any format, and enrich it with software and machine learning solutions that result in better data access, better decisions, and more results.

Healthcare
Traditional methods of sharing files over email, FTP, VPN and even text all have serious security flaws, and run the risk of violating compliance and regulations. Rinodrive offers healthcare professionals a safe way to share specific folders and files of any size.

Research, Development and Engineering
Distributed teams require seamless ways to access, share, and collaborate on content from different sources and in many formats – from specs to detailed drawings. With file sync and collaboration tools, Rinodrive provides a platform to coordinate dispersed and disparate teams.

Financial Services
Rinodrive empowers financial service organisations to: Secure sensitive financial and personal 

Microsaic listed on AIM in 2011 to develop and commercialise micro-engineering chip-based mass spectrometry equipment. Having invested £25m over the last 20 years before and after the IPO, The Company has a robust patent portfolio in cutting-edge technology purpose built for “Industry 4.0” which enables analytical detection and characterisation at the point-of-need, whether within a conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection data at any step in the process workflow.

Executive Chairman

<p>Commercial scale, biodegradable plastic ingredients, Omega-3 oils from microalgae while saving 24% in production costs

Strategically acquired and integrated bio-engineering solutions that are retrofitted into your existing bio-based production site to deliver high-value biodegradable plastic ingredients and Omega 3 at industrial scale. Proven, scaled and commercialized. 

These low-capital cost technologies provide valuable additions to your low-margin, high-volume production output. They improve your gross margins and reduce your costs across the biofuel, dairy, and bio-based production sectors.</p>

Serial entrepreneur with 30+ years scaling medical and diagnostic technology companies from laboratory to global market

productHunt

youtube

Know about Gerard Brandon's work experience, education, bootcamps, certifications, and much more. Gerard Brandon